
Sign up to save your podcasts
Or


Of all the insurance and insurtech highlights of this year, the rise of generative AI (GenAI) has been the most compelling. As we look toward 2025, critical questions remain about GenAI's long-term viability, cost efficiency, and in particular, whether it can replace its human counterparts in claims review, underwriting, and more. Special guest Alex Zukerman, Sapiens' Chief Strategy Officer joins host Pat Ryan to discuss what lies ahead for GenAI in 2025 in our latest podcast.
By SapiensOf all the insurance and insurtech highlights of this year, the rise of generative AI (GenAI) has been the most compelling. As we look toward 2025, critical questions remain about GenAI's long-term viability, cost efficiency, and in particular, whether it can replace its human counterparts in claims review, underwriting, and more. Special guest Alex Zukerman, Sapiens' Chief Strategy Officer joins host Pat Ryan to discuss what lies ahead for GenAI in 2025 in our latest podcast.